ALNYLAM PHARMACEUTICALS, INC. Increase (Decrease) in Income Taxes Payable
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Increase (Decrease) in Income Taxes Payable of -$5.52 million for the 12-month period ending 2010-12-31, per its 10-K filed 2013-02-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2013-02-19
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2010-12-31 was $30.00K, a 99.31% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2010-09-30 was $1.00K.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2010-06-30 was -$1.00K.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for the quarter ending 2010-03-31 was -$5.55M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2010 was -$5.52M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2009 was -$467.00K, a 117.87% decline from fiscal 2008.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in income taxes payable for fiscal 2008 was $2.61M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2010-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $31.00K derived: sum of 2 quarters · filed 2013-02-19 | $30.00K derived: sum of 3 quarters · filed 2013-02-19 | -$5.52M 10-K · filed 2013-02-19 |
| 2010-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $0.00 derived: sum of 2 quarters · filed 2011-11-03 | -$5.55M 10-Q · filed 2011-11-03 | -$1.22M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$5.55M 10-Q · filed 2011-08-03 | -$1.22M derived: sum of 3 quarters · filed 2012-02-13 | -$1.73M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | -$5.55M 10-Q · filed 2011-05-05 | -$1.22M derived: sum of 2 quarters · filed 2012-02-13 | -$1.73M derived: sum of 3 quarters · filed 2012-02-13 | |
| 2009-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $3.81M derived: sum of 2 quarters · filed 2012-02-13 | -$467.00K 10-K · filed 2012-02-13 | |
| 2009-09-30 | -$512.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$4.79M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | -$4.28M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $2.61M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |